Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Mar 28;92(7):2735–2739. doi: 10.1073/pnas.92.7.2735

Genetic control of blood pressure and the angiotensinogen locus.

H S Kim 1, J H Krege 1, K D Kluckman 1, J R Hagaman 1, J B Hodgin 1, C F Best 1, J C Jennette 1, T M Coffman 1, N Maeda 1, O Smithies 1
PMCID: PMC42293  PMID: 7708716

Abstract

Variants of the human angiotensinogen gene have been linked in some studies to increased circulating angiotensinogen levels and essential hypertension. To test for direct causality between genotypes at the angiotensinogen locus and blood pressures, we have studied mice carrying zero, one, two, three, or four functional copies of the murine wild-type angiotensinogen gene (Agt) at its normal chromosomal location. Plasma angiotensinogen levels increase progressively, although not linearly, from zero in the zero-copy animals to 145% of normal in the four-copy animals. Mice of all genotypes are normal at birth, but most zero-copy animals die before weaning. The kidneys of the zero-copy animals show pathological changes as adults, but the kidneys are normal in the other genotypes. One adult zero-copy male tested was fertile. The blood pressures of the one-copy through four-copy animals show significant and almost linear increases of approximately 8 mmHg per gene copy despite their normal compensatory mechanisms being intact. These results establish a direct causal relationship between Agt genotypes and blood pressures.

Full text

PDF
2735

Images in this article

2736Fig. 1
on p.2736
2738Fig. 4
on p.2738

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arngrímsson R., Purandare S., Connor M., Walker J. J., Björnsson S., Soubrier F., Kotelevtsev Y. V., Geirsson R. T., Björnsson H. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet. 1993 Jun;4(2):114–115. doi: 10.1038/ng0693-114. [DOI] [PubMed] [Google Scholar]
  2. Boer P. H., Potten H., Adra C. N., Jardine K., Mullhofer G., McBurney M. W. Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles. Biochem Genet. 1990 Jun;28(5-6):299–308. doi: 10.1007/BF02401419. [DOI] [PubMed] [Google Scholar]
  3. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., Clark A. J. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994 Jun 9;330(23):1629–1633. doi: 10.1056/NEJM199406093302301. [DOI] [PubMed] [Google Scholar]
  4. Clouston W. M., Evans B. A., Haralambidis J., Richards R. I. Molecular cloning of the mouse angiotensinogen gene. Genomics. 1988 Apr;2(3):240–248. doi: 10.1016/0888-7543(88)90008-0. [DOI] [PubMed] [Google Scholar]
  5. Coffman T., Geier S., Ibrahim S., Griffiths R., Spurney R., Smithies O., Koller B., Sanfilippo F. Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol. 1993 Jul 1;151(1):425–435. [PubMed] [Google Scholar]
  6. Copeland N. G., Jenkins N. A., Gilbert D. J., Eppig J. T., Maltais L. J., Miller J. C., Dietrich W. F., Weaver A., Lincoln S. E., Steen R. G. A genetic linkage map of the mouse: current applications and future prospects. Science. 1993 Oct 1;262(5130):57–66. doi: 10.1126/science.8211130. [DOI] [PubMed] [Google Scholar]
  7. Gardes J., Bouhnik J., Clauser E., Corvol P., Menard J. Role of angiotensinogen in blood pressure homeostasis. Hypertension. 1982 Mar-Apr;4(2):185–189. doi: 10.1161/01.hyp.4.2.185. [DOI] [PubMed] [Google Scholar]
  8. Gould A. B., Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res. 1971 Jan;5(1):86–89. doi: 10.1093/cvr/5.1.86. [DOI] [PubMed] [Google Scholar]
  9. Hooper M., Hardy K., Handyside A., Hunter S., Monk M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature. 1987 Mar 19;326(6110):292–295. doi: 10.1038/326292a0. [DOI] [PubMed] [Google Scholar]
  10. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992 Oct 2;71(1):169–180. doi: 10.1016/0092-8674(92)90275-h. [DOI] [PubMed] [Google Scholar]
  11. Kim H. S., Smithies O. Recombinant fragment assay for gene targetting based on the polymerase chain reaction. Nucleic Acids Res. 1988 Sep 26;16(18):8887–8903. doi: 10.1093/nar/16.18.8887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kimura S., Mullins J. J., Bunnemann B., Metzger R., Hilgenfeldt U., Zimmermann F., Jacob H., Fuxe K., Ganten D., Kaling M. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 1992 Mar;11(3):821–827. doi: 10.1002/j.1460-2075.1992.tb05119.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koller B. H., Kim H. S., Latour A. M., Brigman K., Boucher R. C., Jr, Scambler P., Wainwright B., Smithies O. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10730–10734. doi: 10.1073/pnas.88.23.10730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mansour S. L., Thomas K. R., Capecchi M. R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 1988 Nov 24;336(6197):348–352. doi: 10.1038/336348a0. [DOI] [PubMed] [Google Scholar]
  15. Ménard J., el Amrani A. I., Savoie F., Bouhnik J. Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension. 1991 Nov;18(5):705–707. doi: 10.1161/01.hyp.18.5.705. [DOI] [PubMed] [Google Scholar]
  16. Ohkubo H., Kawakami H., Kakehi Y., Takumi T., Arai H., Yokota Y., Iwai M., Tanabe Y., Masu M., Hata J. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5153–5157. doi: 10.1073/pnas.87.13.5153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smithies O., Kim H. S. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3612–3615. doi: 10.1073/pnas.91.9.3612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Walker W. G., Whelton P. K., Saito H., Russell R. P., Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979 May-Jun;1(3):287–291. doi: 10.1161/01.hyp.1.3.287. [DOI] [PubMed] [Google Scholar]
  19. Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C., Farrington P. F., Ogasawara M., Suzumori K., Tomoda S. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993 May;4(1):59–61. doi: 10.1038/ng0593-59. [DOI] [PubMed] [Google Scholar]
  20. Watt G. C., Harrap S. B., Foy C. J., Holton D. W., Edwards H. V., Davidson H. R., Connor J. M., Lever A. F., Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992 May;10(5):473–482. doi: 10.1097/00004872-199205000-00011. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES